OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Technology. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Technology. All rights reserved.
David Luedeker is the principal scientist, solid formulation, for MilliporeSigma, the life science business of Merck KGaA, Darmstadt Germany.
October 07, 2022
Emerging new technologies and disruptive manufacturing concepts are providing new opportunities for pharmaceutical companies.